Dr. Pleyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Center Dr
Bethesda, MD 20814Phone+1 216-444-2200- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2013 - 2016
OtherClass of 2012
Certifications & Licensure
DC State Medical License 2018 - 2024
CA State Medical License 2018 - 2024
OH State Medical License 2013 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsInterruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Clare Sun, Wiestner, A.> ;Leukemia & Lymphoma. 2023 Dec 1
- 12 citationsBTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.Christopher Pleyer, Kerry J Laing, Mir A Ali, Christopher L McClurkan, Susan Soto, Inhye E Ahn, Pia Nierman, Emeline Maddux, Jennifer Lotter, Jeanine Superata, Xin Tia...> ;Blood Advances. 2022 Mar 22
- 17 citationsCOVID-19 vaccines for patients with haematological conditions.Clare Sun, Christopher Pleyer> ;The Lancet. Haematology. 2021 Mar 31
- Join now to see all
Lectures
- Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's T...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hospital Affiliations
Cleveland ClinicCleveland, Ohio
University Hospitals Cleveland Medical CenterCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
